$CNK

Gierhart Wanda Marie sold (to issuer) $751K of CNK

Gierhart Wanda Marie (Chief Marketing & Content Ofc) sold (to issuer) 23,456 shares of Cinemark Holdings, Inc. (CNK) at $32.00 ($0.75M total) on 2026-06-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gierhart Wanda Marie
Published Jun 9, 2026, 9:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNK
Neutral
high confidence
Mentioned
$CNK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNKNeutralLow
01

Why it matters

The disclosure updates the insider transaction record for CNK, but it does not provide new operating, financial, or regulatory information.

02

Market read

Traders may note the insider sale for positioning/flow context, but it is unlikely to drive a fundamental repricing by itself.

03

What to watch

The filing does not indicate whether the sale is part of compensation/withholding mechanics beyond “sale to issuer,” so the signal content is limited without additional context (e.g., other concurrent insider buys/sells).

Relevance 4/10Novelty 6/10Timing: filed 2026-06-09 (same day disclosure)

Background

The article is an SEC Form 4 insider transaction disclosure for Cinemark Holdings, Inc.

Company-level read

Ticker impact

$CNKNeutralHigh confidence
Context

Cinemark officer sold 23,456 shares (~$750.6K) to the issuer on 2026-06-09 under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely noise unless paired with other catalysts.

Evidence & confidence

Form 4 is a primary disclosure, but the transaction is a sale to the issuer under a 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Minimal; this is company-specific insider liquidity rather than an industry/regulatory development.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with management’s view that near-term valuation is less attractive than longer-term fundamentals.

Key entities

  • Cinemark Holdings, Inc.

    CNK; officer (Chief Marketing & Content Officer) reported a sale to the issuer under a 10b5-1 plan.

  • Gierhart Wanda Marie

    Chief Marketing & Content Officer; sold 23,456 shares on 2026-06-09.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMCMedAI 8/10

AMC vs. Cinemark: Which Theater Stock Is the Better Buy Now?

AMC and Cinemark reported record Q2 earnings, with AMC's revenue up 14.2% and Cinemark's surpassing $1B. Both benefit from strong box office trends but face challenges like high costs and debt. AMC's leverage is above target, while Cinemark's performance depends on movie releases and rising electricity costs. Analysts expect strong growth for both, with Cinemark showing slightly better financial strength and growth prospects.

$WBDLow

Warner Bros. Discovery Merger

Cinemark, a Texas-based theater operator, now supports the $110.8B Paramount-Warner Bros. Discovery merger, citing benefits for the box office and industry. AMC and Regal also back the deal, but California and the WGA oppose it, with a trial set for 2027.

$PARAMed

An Offer They Can’t Refuse: Theater Execs Split on Whether to Join Paramount-Warner’s Merger Movement

Paramount Skydance is seeking theater-industry support for its merger with Warner Bros. Discovery amid a legal fight with 12 state attorneys general. Regal and Vue CEOs backed the deal, citing David Ellison’s pledge to release 30 films a year. Paramount reportedly offered contracts for 30 films for at least three years, plus windowing terms and possible penalties.

$CNKMed

Cinemark Holdings, Inc. (CNK): Results of Operations and Financial Condition

Cinemark Holdings, Inc. (CNK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CINEMARK HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Generated all-time high quarterly revenue of $1.1 billion with records across all major revenue categories Delivered Net Income of $141 million, an increase of nearly 50% year-over-year Achieved our highest

$IMAXMed

Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks By Investing.com

Christopher Nolan’s “The Odyssey” is set to open in theaters Friday with a projected $200M worldwide debut. Variety projects $90M to $100M domestic opening across 3,900 North American theaters. IMAX (IMAX) benefits from limited IMAX 70mm capacity. AMC (AMC) got a July 15 upgrade to Buy with a $3.00 target. Marcus (MCS) and Cinemark (CNK) may also gain. IMAX Q2 2026 earnings are due July 23.